Earnings Outlook For Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
Neurocrine Biosciences (NASDAQ:NBIX) is anticipated to release its quarterly earnings report on February 7, 2024, with an expected EPS of $1.15. Historical data shows the company has previously surpassed EPS estimates, leading to slight share price movements. Shares have increased by 35.57% over the last year, indicating a positive outlook among long-term investors. The upcoming earnings report and guidance will be crucial for investor sentiment.
February 06, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neurocrine Biosciences is expected to report an EPS of $1.15 for the upcoming quarter. Historical performance shows positive reactions to earnings beats. With shares up 35.57% over the past year, the earnings report could influence future stock performance.
Given NBIX's history of surpassing EPS estimates and the positive stock performance over the past year, the upcoming earnings report is likely to have a positive short-term impact on the stock price, especially if the company beats the EPS estimate again and provides favorable future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100